Discover more insights into Ii Trials II 시험

Ii Trials sentence examples within progression free survival



Ixabepilone: Overview of Effectiveness, Safety, and Tolerability in Metastatic Breast Cancer


Radiation for Oligometastatic Lung Cancer in the Era of Immunotherapy: What Do We (Need to) Know?

Ii Trials sentence examples within placebo controlled phase



Amisulpride: A Review in Post-Operative Nausea and Vomiting


Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021

Ii Trials sentence examples within two randomized phase



[Radiotherapy for oligometastatic non-small cell lung cancer patients].


Random survival forests identify pathways with polymorphisms predictive of survival in KRAS mutant and KRAS wild-type metastatic colorectal cancer patients


Learn more from Ii Trials II 시험


Ii Trials sentence examples within randomized double blind



Atopische Dermatitis: IL-13-Antikörper macht Hoffnung auf gut verträgliche und lang wirkende Therapieoption


Guselkumab: an anti-IL-23 antibody for the treatment of moderate-to-severe plaque psoriasis

Ii Trials sentence examples within randomized controlled phase



PARP inhibitors in breast and ovarian cancer with BRCA mutations: a meta-analysis of survival


Aromatase and CDK4/6 Inhibitor-Induced Musculoskeletal Symptoms: A Systematic Review

Ii Trials sentence examples within non small cell



Oncogenic KRAS blockade therapy: renewed enthusiasm and persistent challenges


Targeting HER2 May Overtake Chemo, Immunotherapy in NSCLC.

Ii Trials sentence examples within improve overall survival



Approach to Oligometastatic Cancer in the Elderly Patient


Design, organisation and impact of treatment optimisation studies in breast, lung and colorectal cancer: The experience of the European Organisation for Research and Treatment of Cancer.

Ii Trials sentence examples within single arm phase



MP16-08 RE-EVALUATION OF INTRAVESICAL GEMCITABINE IN BACILLUS CALMETTE-GUERIN UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER


Bayesian single-arm phase II trial designs with time-to-event endpoints.

Ii Trials sentence examples within two pivotal phase



Tirbanibulin: First Approval


Romidepsin in combination with low‐dose methotrexate in advanced‐stage mycosis fungoides and Sézary syndrome

Ii Trials sentence examples within cell death protein



Immunomodulatory Effects of Lenvatinib Plus Anti–Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma


Efficacy and safety of toripalimab combined with doxorubicin as first-line treatment for metastatic soft tissue sarcomas: an observational study

Ii Trials sentence examples within chronic kidney disease



Phase 3 Study of Roxadustat to Treat Anemia in Non–Dialysis-Dependant CKD


Nonsteroidal Mineralocorticoid Receptor Antagonism for cardiovascular and renal disorders - new perspectives for combination therapy.

Ii Trials sentence examples within large randomized phase



Neoadjuvant immunotherapy for non-small cell lung cancer: right drugs, right patient, right time?


Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals.

Ii Trials sentence examples within cell lung cancer



Antiemese: Die Neuerungen der ASCO-Guideline im Überblick


PERICARDIAL EFFUSION WITH TAMPONADE PHYSIOLOGY AS AN IMMUNE-RELATED ADVERSE EVENT SECONDARY TO NIVOLUMAB

Ii Trials sentence examples within overall survival benefit



Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR+/HER2− Advanced Breast Cancer after Progression on CDK4/6 Inhibitors (TRINITI-1)


ES19.04 Improving Lung Cancer Survival Through Tracking of Patient Reported Outcomes

Ii Trials sentence examples within advanced ovarian cancer



Rotational intraperitoneal pressurized aerosol chemotherapy in a porcine model.


Acceptability and feasibility of early palliative care among women with advanced epithelial ovarian cancer: A Canadian randomized controlled pilot study.

Ii Trials sentence examples within death protein 1



Anti-PD-(L)1 for KRAS-mutant advanced non-small–cell lung cancers: a meta-analysis of randomized–controlled trials

Ii Trials sentence examples within neoadjuvant chemotherapy followed



Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review and meta-analysis

Ii Trials sentence examples within metastatic breast cancer



Experience in treating BRCA-associated breast cancer. The BRCA-history of a family

Ii Trials sentence examples within Phase Ii Trials



[Radiotherapy for oligometastatic non-small cell lung cancer patients].


Systematic review of combinations of targeted or immunotherapy in advanced solid tumors

Ii Trials sentence examples within Freedom Ii Trials



Disability improvement as a clinically relevant outcome in clinical trials of relapsing forms of multiple sclerosis.


Baseline characteristics and effects of fingolimod on cognitive performance in patients with relapsing-remitting multiple sclerosis.

Ii Trials sentence examples within ii trials evaluating



Neurotoxicities of Novel Non-Steroidal Anti-Androgens for Prostate Cancer: A Systematic Review and Meta-Analysis.


Characterizing tumor shrinkage as a measure of clinical benefit for immune checkpoint inhibitors

Ii Trials sentence examples within ii trials showed



A randomised evaluation of low‐dose cytosine arabinoside (ara‐C) plus tosedostat versus low‐dose ara‐C in older patients with acute myeloid leukaemia: results of the LI‐1 trial


Amisulpride: A Review in Post-Operative Nausea and Vomiting

Ii Trials sentence examples within ii trials comparing



Daratumumab, pomalidomide, and dexamethasone in relapsed refractory multiple myeloma (RRMM): A comparison with contemporary clinical trials.


Lymph node dissection for gastric cancer: Establishment of D2 and the current position of splenectomy in Europe and Japan.

Ii Trials sentence examples within ii trials testing



Risk and Benefit for Targeted Therapy Agents in Pediatric Phase II Trials in Oncology: A Systematic Review with a Meta-Analysis


Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review.

Ii Trials sentence examples within ii trials investigating



Two decades of targeted therapies in acute myeloid leukemia


Therapeutic outcome of early-phase clinical trials in multiple myeloma: a meta-analysis

Ii Trials sentence examples within ii trials demonstrating



Perspectives on PARP inhibitors as pharmacotherapeutic strategies for breast cancer


Direct oral anticoagulant use in special populations

Ii Trials sentence examples within ii trials suggest



Approach to Oligometastatic Cancer in the Elderly Patient


Is There an Indication for First Line Radiotherapy in Primary CNS Lymphoma?

Ii Trials sentence examples within ii trials currently



Omidenepag isopropyl ophthalmic solution for open-angle glaucoma and ocular hypertension: an update


Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification Strategy

Ii Trials sentence examples within ii trials showing



Emerging and current treatment combinations for transplant-ineligible multiple myeloma patients.


Mix and match COVID-19 vaccines: potential benefit and perspective from India

Ii Trials sentence examples within ii trials conducted



ES19.04 Improving Lung Cancer Survival Through Tracking of Patient Reported Outcomes


Estimation of the binomial probabilities in a two-stage phase II clinical trial with two co-primary endpoints.

Ii Trials sentence examples within ii trials designed



Phase Ib/II open-label, randomized evaluation of atezolizumab (atezo) + Imprime PGG (Imprime) + bevacizumab (bev) vs regorafenib (rego) in MORPHEUS: Microsatellite-stable (MSS) metastatic colorectal cancer (mCRC).


Phase Ib/II open-label, randomized evaluation of efficacy and safety of atezolizumab plus isatuximab versus regorafenib in MORPHEUS-colorectal cancer.

Ii Trials sentence examples within ii trials involving



Ang2 inhibitors and Tie2 activators: potential therapeutics in perioperative treatment of early stage cancer


HCL — vemurafenib plus rituximab holds promise

Ii Trials sentence examples within ii trials tested



Head and Neck Cancer Clinical Research on ClinicalTrials.gov: An Opportunity for Radiation Oncologists


The Early Impact of the IDEA Collaboration Results: How the Results Changed Prescribing Practice

Ii Trials sentence examples within ii trials enrolling



Two decades of research toward the treatment of locally advanced and metastatic pancreatic cancer: Remarkable effort and limited gain.


Dynamics of eligibility criteria for central nervous system metastases in non-small cell lung cancer randomized clinical trials over time: A systematic review.

More Ii Trials II 시험 sentence examples
10.1007/s40262-021-01019-9

Effect of Ponesimod Exposure on Total Lymphocyte Dynamics in Patients with Multiple Sclerosis



Ovarian Cancer in the Era of Immune Checkpoint Inhibitors: State of the Art and Future Perspectives



Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer.


More Ii Trials II 시험 sentence examples
10.1007/s00277-021-04404-3

Treatment of relapsed/refractory multiple myeloma in the bortezomib and lenalidomide era: a systematic review and network meta-analysis



Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial



Successive Osteosarcoma Relapses after the First Line O2006/Sarcome-09 Trial: What Can We Learn for Further Phase-II Trials?


More Ii Trials II 시험 sentence examples
10.1007/s40274-021-7555-9

Cost-effectiveness framework for evaluating COVID-19 therapies


More Ii Trials II 시험 sentence examples
10.1080/21678707.2021.1882299

Phase three clinical trials in idiopathic pulmonary fibrosis



First-Line PARP Inhibitors—Emerging Side Effects Require Caution: A Case of PARPi-Induced Pneumonitis



O07: Efficacy of abrocitinib monotherapy in patients with prior exposure to systemic treatments: pooled results from the JADE MONO‐1 and JADE MONO‐2 studies


More Ii Trials II 시험 sentence examples
10.1101/2021.06.23.21259415

Use of recently vaccinated individuals to detect bias in test-negative case-control studies of COVID-19 vaccine effectiveness


More Ii Trials II 시험 sentence examples
10.1016/j.lungcan.2021.07.005

On target: Rational approaches to KRAS inhibition for treatment of non-small cell lung carcinoma.



Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer



Perspectives in liver redox imbalance: Toxicological and pharmacological aspects underlying iron overloading, nonalcoholic fatty liver disease, and thyroid hormone action.


More Ii Trials II 시험 sentence examples
10.1080/14760584.2021.1889094

Biological strategies and political hurdles in developing malaria vaccines


More Ii Trials II 시험 sentence examples
10.1158/1538-7445.SABCS20-PD13-06

Abstract PD13-06: Incidence and management of central nervous system metastases in patients with inflammatory breast cancer


More Ii Trials II 시험 sentence examples
10.1158/2159-8290.CD-21-0697

Futibatinib, an irreversible FGFR1-4 inhibitor, in patients with advanced solid tumors harboring FGF/FGFR aberrations: a phase I dose-expansion study.



Collaborative Platform Trials to Fight COVID‐19: Methodological and Regulatory Considerations for a Better Societal Outcome


More Ii Trials II 시험 sentence examples
10.20944/preprints202108.0037.v1

Ovarian Cancer in the Era of Immune Checkpoint Inhibitors: State of the Art and Future Perspectives.



The Evolving Role of FGFR2 Inhibitors in Intrahepatic Cholangiocarcinoma: From Molecular Biology to Clinical Targeting



COVID-19 and the liver: What do we know so far?


More Ii Trials II 시험 sentence examples
10.1080/17512433.2021.1901574

Pharmacokinetic/pharmacodynamic target attainment in critically ill renal patients on antimicrobial usage: focus on novel beta-lactams and beta lactams/beta-lactamase inhibitors


More Ii Trials II 시험 sentence examples
10.1101/2021.07.30.21260912

Measuring vaccine efficacy against infection and disease in clinical trials: sources and magnitude of bias in COVID-19 vaccine efficacy estimates


More Ii Trials II 시험 sentence examples
10.1038/s41536-021-00161-z

Further validation of the efficacy of mesenchymal stem cell infusions for reducing mortality in COVID-19 patients with ARDS



Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer


More Ii Trials II 시험 sentence examples
10.1007/s40274-021-7432-6

Sorafenib not a cost-effective treatment option in locally advanced hepatocellular carcinoma



Landscape of Biomarkers and Actionable Gene Alterations in Adenocarcinoma of GEJ and Stomach—A Real World Data Analysis



Successful bailout stenting strategy against rare spontaneous retrograde dissection of partially absorbed magnesium-based resorbable scaffold: A case report


More Ii Trials II 시험 sentence examples
10.1007/s13311-021-01055-0

Targeting Neuromyelitis Optica Pathogenesis: Results from Randomized Controlled Trials of Biologics.


More Ii Trials II 시험 sentence examples
10.1016/j.critrevonc.2021.103505

A Bayesian network meta-analysis on systemic therapy for previously treated gastric cancer.



Clinical Trial Availability by Location for 1000 Simulated AYA Patients.



Value of Adaptive Trials and Surrogate Endpoints for Clinical Decision-Making in Rare Cancers


Ii Trials II 시험


Ii Trials II 시험
Encyclopedia 백과사전